Synaptogenix shareholders approve stock issuance authorization and equity plan increase at annual meeting

TAO Synergies Inc.

Elected directors Silverman (369,569 for) and Singer (367,990 for); broker non-votes 368,218.
Authorized board to issue shares >20% of outstanding under Sept 10, 2024 purchase agreement; 246,470 for, 100,776 against.
Approved amendment to 2020 Equity Plan raising authorized shares from 175,000 to 675,000; 270,829 for, 194,623 against.
Ratified Stephano Slack as auditor for FY2024; 690,006 for, 143,414 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.